TOPIRAMATE ER 200 MG CAPSULE

Topiramate
$22.2558per EA

Strength

200 mg/1

Manufacturer

Endo USA Inc.

NDC

10370036801

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA205976

On Market Since

3/24/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

+0.1%

3M

-8.4%

6M

-13.3%

1Y

-23.7%

3Y

N/A

5Y

N/A

All

-34.2%